Patients in states that expanded Medicaid eligibility had 25.4% more prescriptions filled than in 2013, compared with a 2.8% prescription increase in states that did not expand eligibility.
The first full year of enrollment under expanded Medicaid and health insurance exchanges had a substantial impact on healthcare spending in 2014.
The rate of uninsured individuals in the United States dropped by 5.1%, as 15.7 million gained health insurance coverage last year under the Affordable Care Act and continued economic recovery, according to an annual medication use report by the IMS Institute for Healthcare Informatics.
Patients in states that expanded Medicaid eligibility had 25.4% more prescriptions filled than in 2013, compared with a 2.8% prescription increase in states that did not expand eligibility.
Read more at Pharmacy Times: http://bit.ly/1DE1vr6
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More